Ocuphire Announces Publication of ORION-1 Phase 2 Results for Nyxol in Clinical Ophthalmology and Presentation at the January OIS Presbyopia Innovation Showcase
Jotup,
The findings of the ORION-1 trial and our comprehensive end of Phase 2 meeting with the FDA in May 2020 set the direction for…